Gaois

Search direction

Search mode

Filter results

Collections

49 results in 4 documents

  1. #2505888

    Feistí solaschomharthaíochta (LSD)

    Light signalling devices (LSD)

    Commission Delegated Regulation (EU) 2022/1398 of 8 June 2022 amending Regulation (EU) 2019/2144 of the European Parliament and of the Council to take into account technical progress and regulatory developments concerning amendments to Vehicle Regulations adopted in the context of the United Nations Economic Commission for Europe (Text with EEA relevance)

  2. #2720218

    Iarscríbhinn IX maidir le vacsaíniú in aghaidh ionfhabhtú le galar an chraicinn chnapánaigh (LSD).

    Annex IX on vaccination against infection with lumpy skin disease virus (LSD).

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  3. #2720450

    Ionfhabhtú le galar an chraicinn chnapánaigh (LSD)

    Infection with lumpy skin disease virus (LSD)

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  4. #2720451

    COINNÍOLLACHA SONRACHA MAIDIR LE CUR CHUN FEIDHME VACSAÍNITHE PRÓIFIOLACSAIGH ÉIGEANDÁLA CHUN LSD A CHOSC AGUS A RIALÚ

    SPECIFIC CONDITIONS FOR THE IMPLEMENTATION OF EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF LSD

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  5. #2720508

    rinneadh tástáil um imoibriú slabhrúil polaiméaráise ar an seamhan, a raibh torthaí diúltacha uirthi, chun víreas ghalar an chraicinn chnapánaigh a bhrath;

    the semen was subjected, with negative results, to a PCR test to detect LSD;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  6. #2720529

    TRÉIMHSÍ ATHSHLÁNAITHE LE HAGHAIDH VÍREAS GHALAR AN CHRAICINN CHNAPÁNAIGH TAR ÉIS VACSAÍNIÚ PRÓIFIOLACSACH ÉIGEANDÁLA

    RECOVERY PERIODS FOR LSD FOLLOWING EMERGENCY PROTECTIVE VACCINATION

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  7. #2720530

    An cineál faireachais chun easpa tarlaithe víreas ghalar an chraicinn chnapánaigh a léiriú

    Type of surveillance to demonstrate the absence of occurrence of LSD

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  8. #2796075

    Tháinig galar an chraicinn chnapánaigh chun cinn san Aontas den chéad uair in 2015 sa Ghréig.

    LSD occurred in the Union for the first time in 2015 in Greece.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  9. #2796007

    Le Rialachán Tarmligthe (AE) 2023/361 déantar foráil freisin maidir le tréimhsí athshlánaithe le haghaidh ghalar an chraicinn chnapánaigh, i ndiaidh vacsaíniú próifiolacsach éigeandála, ar tréimhsí idir 8 agus 26 mhí iad, de réir an chineál faireachais, an chrios vacsaínithe, agus an tráth a mharaítear an cás deiridh de ghalar an chraicinn chnapánaigh nó an tráth a rinneadh an vacsaíniú deiridh.

    Delegated Regulation (EU) 2023/361 also provides for recovery periods for LSD, following emergency protective vaccination, that range between 8 and 26 months, depending on the type of surveillance, the vaccination zone, and the time of the slaughter or killing of the last LSD case and/or the time of the last vaccination.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  10. #2796008

    Ó bhí 2017 ann níor tuairiscíodh aon ráig de ghalar an chraicinn chnapánaigh san Eoraip, cé gur taifeadadh galar an chraicinn chnapánaigh i gcodanna d’Anatóil na Tuirce go dtí 2021 agus cé go bhfuil sé fós i láthair sa Rúis agus á leathadh go fóill san Áise, ag déanamh difear do thíortha i bhfo-ilchríoch na hIndia, san Áise Thoir agus in Oirdheisceart na hÁise.

    Since 2017, no LSD outbreaks have been reported in Europe although LSD was recorded until 2021 in parts of Anatolia, Türkiye and remains present in Russia while it continues to spread in Asia, affecting countries of the Indian subcontinent, East Asia and South East Asia.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  11. #2796013

    Agus pleananna vacsaínithe na Bulgáire agus na Gréige le haghaidh 2023, an staid eipidéimeolaíoch a mhéid a bhaineann leis an ngalar sin san Aontas, agus an tréimhse athshlánaithe maidir le galar an chraicinn chnapánaigh a leagtar síos i Rialachán Tarmligthe (AE) 2023/361 á gcur san áireamh, beidh feidhm ag an gCinneadh seo go dtí an 31 Lúnasa 2024,

    Taking into account the LSD vaccination plans of Bulgaria and Greece for 2023, the epidemiological situation as regards that disease in the Union, and the recovery period for LSD, as laid down in Delegated Regulation (EU) 2023/361, this Decision should apply until 31 August 2024,

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  12. #1825529

    Togra le haghaidh Fhorlíonadh 2 a ghabhann leis an tsraith bhunaidh de Rialachán Uimh. 148 de chuid NA maidir le feistí solaschomharthaíochta (LSD)

    Proposal for Supplement 2 to the original series of UN Regulation No 148 on Light-Signalling Devices (LSD)

    Council Decision (EU) 2020/287 of 27 February 2020 on the position to be taken on behalf of the European Union in the relevant Committees of the United Nations Economic Commission for Europe as regards the proposals for modifications to UN Regulations Nos 10, 26, 28, 46, 48, 51, 55, 58, 59, 62, 79, 90, 106, 107, 110, 117, 121, 122, 128, 144, 148, 149, 150, 151 and 152, as regards the proposals for modifications to Global Technical Regulations Nos 3, 6 and 16, as regards the proposal for amendments to Consolidated Resolution R.E.5, and as regards the proposals for authorisations to develop an amendment to GTR No 6 and to develop a new GTR on the Determination of Electrified Vehicle Power

  13. #2720453

    Crios vacsaínithe I: crios vacsaínithe ina gcuirtear vacsaíniú próifiolacsach éigeandála chun feidhme i limistéir nach bhfuil LSD deimhnithe iontu;

    Vaccination zone I: vaccination zone where emergency protective vaccination is implemented in areas where LSD has not been confirmed;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  14. #2720454

    Crios vacsaínithe II: crios vacsaínithe ina gcuirtear vacsaíniú próifiolacsach éigeandála chun feidhme i limistéir a bhfuil ráigeanna LSD deimhnithe iontu.

    Vaccination zone II: vaccination zone where emergency protective vaccination is implemented in areas where outbreaks of LSD have been confirmed.

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  15. #2720460

    COINNÍOLLACHA SONRACHA MAIDIR LE FAIREACHAS TREISITHE CLINICIÚIL AGUS SAOTHARLAINNE ATÁ LE CUR CHUN FEIDHME SNA CRIOSANNA VACSAÍNITHE AGUS PEIREA-VACSAÍNITHE LE LINN VACSAÍNIÚ PRÓIFIOLACSACH ÉIGEANDÁLA CHUN LSD A CHOSC AGUS A RIALÚ

    SPECIFIC CONDITIONS FOR THE REINFORCED CLINICAL AND LABORATORY SURVEILLANCE TO BE IMPLEMENTED IN THE VACCINATION AND PERI-VACCINATION ZONES DURING EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF LSD

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  16. #2720505

    rinneadh seiceáil chliniciúil ar na hainmhithe bronntacha 28 lá roimh dháta an bhailithe, agus le linn na tréimhse bailithe go léir chomh maith, agus níor léirigh siad aon siomptóm cliniciúil de víreas ghalar an chraicinn chnapánaigh;

    the donor animals were clinically checked 28 days prior to the date of collection, as well as throughout the entire collection period, and did not show any clinical symptoms of LSD;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  17. #2720535

    8 mí tar éisan vacsaínithe deiridh má úsáideadh vacsaíniú próifiolacsach éigeandála (i gcrios vacsaínithe I), tréimhse ar lena linn nár léiríodh le faireachas cliniciúil agus saotharlainne aon tarlú de LSD

    8 months after the last vaccination if emergency protective vaccination has been used (in vaccination zone I), and during which period clinical and laboratory surveillance has demonstrated no occurrence of LSD

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  18. #2795997

    Ina theannta sin, maidir leis an gCróit agus an Bhoisnia agus an Heirseagaivéin, tíortha nach raibh buailte le galar an chraicinn chnapánaigh, chuir siad vacsaíniú chun feidhme mar bheart coisctheach, i bhfianaise an galar a bheith ag tarlú i dtíortha comharsanacha.

    In addition, Croatia and Bosnia and Herzegovina, that were not affected by LSD, implemented vaccination as a preventive measure, in view of disease occurrence in neighbouring countries.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  19. #2795998

    Glacadh Rialachán Cur Chun Feidhme (AE) 2021/1070 ón gCoimisiún faoi chuimsiú Rialachán (AE) 2016/429, agus leagtar síos leis bearta speisialta rialaithe in aghaidh ghalar an chraicinn chnapánaigh ar feadh tréimhse teoranta ama.

    Commission Implementing Regulation (EU) 2021/1070 was adopted within the framework of Regulation (EU) 2016/429, and it lays down special control measures against LSD for a limited period of time.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  20. #2796000

    Go sonrach, le Rialachán Cur Chun Feidhme (AE) 2021/1070 sainítear na criosanna i mBallstát ina ndéantar vacsaíniú in aghaidh ghalar an chraicinn chnapánaigh, agus na rialacha speisialta rialaithe galar laistigh de gach crios.

    More particularly, Implementing Regulation (EU) 2021/1070, defines the zones of a Member State, where vaccination against LSD is carried out, and the special disease control rules within each zone.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  21. #2796009

    I bhfianaise na staide eipidéimeolaíche atá ann san Eoraip, gach tír in Oirdheisceart na hEorpa a chuir vacsaíniú in aghaidh ghalar an chraicinn chnapánaigh chun feidhme, cé is moite den Bhulgáir, den Ghréig agus den Tuirc, tá deireadh curtha acu leis an vacsaíniú anois.

    In view of the favourable epidemiological situation in Europe, all countries in South East Europe that implemented vaccination against LSD have now ceased, except for Bulgaria, Greece and Türkiye.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  22. #2720461

    COINNÍOLLACHA SONRACHA MAIDIR LE GLUAISEACHTAÍ AINMHITHE AGUS TÁIRGÍ A THOIRMEASC AGUS MAIDIR LE MAOLÚ A DHEONÚ I gCOMHRÉIR LE hAIRTEAGAL 13, I gCRIOSANNA VACSAÍNITHE INA nDÉANTAR VACSAÍNIÚ PRÓIFIOLACSACH ÉIGEANDÁLA CHUN GALAR AN CHRAICINN CHNAPÁNAIGH A CHOSC AGUS A RIALÚ

    SPECIFIC CONDITIONS FOR THE PROHIBITION OF MOVEMENTS OF ANIMALS AND PRODUCTS AND FOR GRANTING A DEROGATION IN ACCORDANCE WITH ARTICLE 13, IN VACCINATION ZONES WHERE EMERGENCY PROTECTIVE VACCINATION FOR PREVENTION AND CONTROL OF LSD IS CARRIED OUT

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  23. #2720470

    rinneadh na hainmhithe den speiceas buaibheach sa choinsíneacht a vacsaíniú in aghaidh ionfhabhtú víreas ghalar an chraicinn chnapánaigh 28 lá ar a laghad roimh an dáta seolta agus tá siad fós laistigh den tréimhse imdhíonachta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta sin;

    the bovine animals in the consignment must have been vaccinated against LSD at least 28 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on that date;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  24. #2720471

    rinneadh gach ainmhí den speiceas buaibheach ar coimeád i mbunaíocht tionscnaimh na gcoinsíneachtaí sin a vacsaíniú nó a athvacsaíniú in aghaidh ionfhabhtú víreas ghalar an chraicinn chnapánaigh 28 lá ar a laghad roimh an dáta seolta agus tá siad fós laistigh den tréimhse imdhíonachta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta sin nó tá siad fós laistigh den tréimhse imdhíonachta ar spreag vacsaíniú nó imdhíonacht ón máthair í roimhe sin ar an dáta seolta;

    all the other bovine animals kept in the same establishment of origin as the bovine animals in the consignment must have been vaccinated against LSD at least 28 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on that date or remain within the immunity period induced by previous vaccination or maternal immunity on the date of dispatch;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  25. #2720476

    rinneadh vacsaíniú ar na hainmhithe den speiceas buaibheach sa choinsíneacht in aghaidh ionfhabhtú víreas ghalar an chraicinn chnapánaigh 60 lá ar a laghad roimh an dáta seolta agus tá siad fós laistigh den tréimhse imdhíonachta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta seolta;

    the bovine animals in the consignment must have been vaccinated against LSD at least 60 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on the date of dispatch;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  26. #2720477

    i bhfoisceacht 20 km ar a laghad de bhunaíocht tionscnaimh na gcoinsíneachtaí sin, ní raibh aon ráig de víreas ghalar an chraicinn chnapánaigh le linn tréimhse 3 mhí ar a laghad roimh an dáta seolta; agus

    within a radius of at least 20 km around the establishment of origin of such consignments, there have been no outbreaks of LSD during a period of at least three months prior to the date of dispatch; and

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  27. #2720478

    rinneadh gach ainmhí den speiceas buaibheach atá ar coimeád i bhfoisceacht 50 km de bhunaíocht tionscnaimh na coinsíneachta a vacsaíniú nó a athvacsaíniú in aghaidh víreas ghalar an chraicinn chnapánaigh 60 lá ar a laghad roimh an dáta seolta agus tá siad fós laistigh den tréimhse imdhíonachta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta sin nó laistigh den tréimhse imdhíonachta ar spreag imdhíonacht ón máthair í;

    all bovine animals kept in 50 km around the establishment of origin of the consignment must have been vaccinated or revaccinated against LSD at least 60 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on that date or within the immunity period induced by maternal immunity;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  28. #2720480

    comhlíonfaidh na hainmhithe aon ráthaíocht sláinte ainmhithe, bunaithe ar thoradh fabhrach ar mheasúnú riosca arna dhéanamh ar bhearta in aghaidh leathadh víreas ghalar an chraicinn chnapánaigh a cheanglóidh údarás inniúil an Bhallstáit tionscnaimh agus a fhormheasfaidh údarás inniúil an Bhallstáit trasnaithe nó an Bhallstáit cinn scríbe, roimh an dáta seolta;

    the animals must comply with any animal health guarantee, based on the favourable outcome of a risk assessment of measures against the spread of LSD required by the competent authority of the Member State of origin and approved by the competent authority of the Member States of passage and destination, prior to the date of dispatch;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  29. #2720481

    níor deimhníodh aon ráig de víreas ghalar an chraicinn chnapánaigh i bhfoisceacht 20 km ar a laghad de bhunaíocht tionscnaimh na gcoinsíneachtaí sin ar feadh tréimhse 3 mhí ar a laghad roimh an dáta seolta; agus

    there must have been no confirmed outbreaks of LSD within a radius of at least 20 km around the establishment of origin of such consignments for a period of at least three months prior to the date of dispatch; and

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  30. #2720482

    rinneadh gach ainmhí den speiceas buaibheach atá ar coimeád i bhfoisceacht 50 km de bhunaíocht tionscnaimh na coinsíneachta a vacsaíniú nó a athvacsaíniú in aghaidh víreas ghalar an chraicinn chnapánaigh 60 lá ar a laghad roimh an dáta seolta agus tá siad fós laistigh den tréimhse imdhíonachta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta sin nó laistigh den tréimhse imdhíonachta ar spreag imdhíonacht ón máthair í.

    all bovine animals kept in 50 km around the establishment of origin of the consignment must have been vaccinated or revaccinated against LSD at least 60 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on that date or within the immunity period induced by maternal immunity.

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  31. #2720486

    comhlíonfaidh na hainmhithe den speiceas buaibheach sa choinsíneacht gach ráthaíocht sláinte ainmhithe, ar bhonn toradh fabhrach ar mheasúnú riosca arna dhéanamh ar bhearta in aghaidh leathadh víreas ghalar an chraicinn chnapánaigh a cheanglóidh údarás inniúil an Bhallstáit tionscnaimh agus a fhormheasfaidh údarás inniúil an Bhallstáit trasnaithe nó an Bhallstáit cinn scríbe, roimh an dáta seolta;

    the bovine animals in the consignment shall comply with any animal health guarantee, based on the favourable outcome of a risk assessment of measures against the spread of LSD required by the competent authority of the Member State of origin and approved by the competent authority of the Member States of passage and destination, prior to the date of dispatch;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  32. #2720487

    rinneadh gach ainmhí eile den speiceas buaibheach atá ar coimeád sa bhunaíocht tionscnaimh chéanna leis na hainmhithe den speiceas buaibheach sa choinsíneacht a vacsaíniú in aghaidh ionfhabhtú víreas ghalar an chraicinn chnapánaigh 28 lá ar a laghad roimh an dáta seolta agus tá siad fós laistigh den tréimhse imdhíonachta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta sin nó fós laistigh den tréimhse imdhíonachta ar spreag vacsaíniú nó imdhíonacht ón máthair í roimhe sin ar an dáta sin;

    all other bovine animals kept in the same establishment of origin as the bovine animals in the consignment must have been vaccinated against LSD at least 28 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on that date or remain within the immunity period induced by previous vaccination or maternal immunity on that date;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  33. #2720491

    tá na hainmhithe den speiceas buaibheach ar coimeád i mbunaíocht ó rugadh iad, nó ar feadh tréimhse 28 lá ar a laghad roimh an dáta seolta, i mbunaíocht nár deimhníodh aon ráig d’ionfhabhtú víreas ghalar an chraicinn chnapánaigh i bhfoisceacht 20 km ar a laghad di le linn na 3 mhí roimh an dáta seolta;

    the bovine animals must have been resident since birth, or for a period of at least 28 days prior to the date of dispatch, in an establishment where, within a radius of at least 20 km, no outbreak of LSD has been confirmed during the three months prior to the date of dispatch;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  34. #2720492

    rinneadh gach ainmhí den speiceas buaibheach i bhfoisceacht 50 km de bhunaíocht tionscnaimh na coinsíneachta a vacsaíniú nó a athvacsaíniú in aghaidh víreas ghalar an chraicinn chnapánaigh 60 lá ar a laghad roimh an dáta seolta agus tá siad fós laistigh den tréimhse imdhíonachta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta sin nó laistigh den tréimhse imdhíonachta ar spreag imdhíonacht ón máthair í;

    all bovine animals in 50 km around the establishment of origin of the consignment must have been vaccinated or revaccinated against LSD, at least 60 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on that date or within the immunity period induced by maternal immunity;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  35. #2720494

    rinneadh gach ainmhí den speiceas buaibheach ar coimeád i mbunaíocht tionscnaimh na gcoinsíneachtaí sin a vacsaíniú nó a athvacsaíniú in aghaidh ionfhabhtú víreas ghalar an chraicinn chnapánaigh 28 lá ar a laghad roimh an dáta seolta agus tá siad fós laistigh den tréimhse imdhíonachta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta sin nó tá siad fós laistigh den tréimhse imdhíonachta ar spreag vacsaíniú nó imdhíonacht ón máthair í roimhe sin ar an dáta sin; agus

    all other bovine animals kept in the establishment of origin of such consignments must have been vaccinated against LSD at least 28 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on that date or remain within the immunity period induced by previous vaccination or maternal immunity on that date; and

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  36. #2720495

    rinneadh na hainmhithe den speiceas buaibheach ar coimeád i mbunaíocht tionscnaimh na gcoinsíneachtaí sin a vacsaíniú in aghaidh ionfhabhtú víreas ghalar an chraicinn chnapánaigh 28 lá ar a laghad roimh an dáta seolta i gcomhréir le treoracha mhonaróir na vacsaíní ar an dáta sin nó is sliocht neamhvacsaínithe iad atá níos lú ná 6 mhí d’aois agus a rugadh do mháithreacha vacsaínithe 28 lá ar a laghad roimh bhreith a bhí fós laistigh den tréimhse imdhíonachta i gcomhréir leis an monaróir vacsaíní ar dháta na breithe, agus féadfar iad a aistriú go dtí bunaíocht eile.

    the bovine animals must have been vaccinated against LSD at least 28 days prior to the date of dispatch and remain within the immunity period in accordance with the instructions of the vaccine manufacturer on that date or are unvaccinated offspring less than four months old, born to dams vaccinated at least 28 days prior to parturition that remained within the immunity period according to the vaccine manufacturer on the date of parturition, and may be moved to another establishment.

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  37. #2720502

    bhí siad vacsaínithe agus athvacsaínithe in aghaidh víreas ghalar an chraicinn chnapánaigh i gcomhréir le treoracha mhonaróir na vacsaíne a úsáideadh, agus ní mór gur tugadh an chéad vacsaíniú ar a laghad 60 lá roimh dháta bailithe an tseamhain, na n-úicítí nó an tsutha; nó

    vaccinated and revaccinated against LSD according to the manufacturer’s instructions of the vaccine used, and the first vaccination must have been administered at least 60 days prior to the date of collection of the semen, oocytes or embryo, or

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  38. #2720503

    rinneadh tástáil shéireolaíoch orthu, tástáil a raibh torthaí diúltacha uirthi chun antasubstaintí sonracha in aghaidh víreas ghalar an chraicinn chnapánaigh a bhrath lá an bhailithe agus ar a laghad 28 lá tar éis na tréimhse bailithe a mhéid a bhaineann le seamhan nó ar lá an bhailithe a mhéid a bhaineann le suthanna agus úicítí;

    subjected, with negative results, to a serological test to detect specific antibodies against LSD virus on the day of the collection and at least 28 days after the period of collection as regards semen or on the day of collection as regards embryos and oocytes;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  39. #2720504

    coimeádadh na hainmhithe bronntacha, le linn na 60 lá roimh dháta bailithe an tseamhain, na n-úicítí nó na suthanna, in ionad inseamhnaithe shaorga nó i mbunaíocht iomchuí eile, nár deimhníodh aon ráig de víreas ghalar an chraicinn chnapánaigh i bhfoisceacht 20 km ar a laghad de le linn na 3 mhí roimh dháta bailithe an tseamhain, na n-úicítí nó na suthanna;

    the donor animals were kept, during the 60 days prior to the date of collection of the semen, oocytes or embryos, in an artificial insemination centre or other appropriate establishment where, within a radius of at least 20 km, no outbreak of LSD has been confirmed during the three months prior to the date of collection of the semen, oocytes or embryos;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  40. #2720507

    cuireadh na hainmhithe bronntacha faoi réir tástála um imoibriú slabhrúil polaiméaráise (PCR) chun LSD a bhrath, a raibh torthaí diúltach uirthi, a rinneadh ar shamplaí fola a bailíodh ag tús bhailiú an tseamhain agus gach 14 lá ar a laghad ina dhiaidh sin le linn thréimhse bailithe an tseamhain nó ar an lá bailithe maidir le suthanna agus úicítí;

    the donor animals were subjected, with negative results, to a polymerase chain reaction (PCR) test to detect LSD conducted on blood samples collected at the commencement of collection of the semen and at least every 14 days thereafter during the semen collection period or on the day of collection for embryos and oocytes;

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  41. #2720509

    aon cheann scríbe atá lonnaithe sa Bhallstát céanna nó i mBallstát eile nó, i gcás chrios vacsaínithe I, i dtríú tír ar choinníoll go gcomhlíonfaidh na hainmhithe bronntacha, i dteannta na gcoinníollacha a leagtar síos i bpointe (a), aon ráthaíocht iomchuí eile maidir le sláinte ainmhithe, bunaithe ar thoradh dearfach ar mheasúnú riosca arna dhéanamh ar thionchar an tseolta sin agus ar na bearta in aghaidh leathadh víreas ghalar an chraicinn chnapánaigh, a cheanglaíonn údarás inniúil an Bhallstáit ina bhfuil siad bunaithe agus a fhormheasann údaráis inniúla Bhallstáit áiteanna trasnaithe agus seolta, sula seoltar an seamhan, na húicítí nó na suthanna sin.

    any destination located in the same or another Member State or, in case of a vaccination zone I, to a third country provided that, in addition to the conditions laid down in point (a), the donor animals comply with any other appropriate animal health guarantees, based on a positive outcome of a risk assessment of the impact of such dispatch and of the measures against the spread of LSD, required by the competent authority of the Member State of the establishment of origin and approved by the competent authorities of the Member States of the places of passage and of destination, prior to the dispatch of such semen, oocytes or embryos.

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  42. #2720523

    i gcás gruth buí, bainne agus táirgí déiríochta, aon cheann scríbe atá lonnaithe in aon limistéar de chuid an Bhallstáit céanna nó Ballstáit eile ar choinníoll go ndearnadh cóireáil maolaithe riosca orthu maidir le víreas ghalar an chraicinn chnapánaigh, mar a leagtar amach in Iarscríbhinn VII a ghabhann le Rialachán Tarmligthe (AE) 2020/687.

    in the case of colostrum, milk and dairy products, any destination located in any area of the same or another Member State provided that they have been subjected to a risk-mitigating treatment for LSD, as set out in Annex VII to Delegated Regulation (EU) 2020/687.

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  43. #2720531

    14 mhí tar éis mharú seamlais nó mharú an cháis dheireanaigh, nó tar éis anvacsaínithe deiridh má úsáideadh vacsaíniú próifiolacsach éigeandála (i gcrios vacsaínithe II), cibé acu is déanaí a tharla, tréimhse ar lena linn nár léiríodh le faireachas cliniciúil agus saotharlainne aon tarlú de LSD

    14 months after the slaughter or killing of the last case, or after the last vaccination if emergency protective vaccination has been used (in vaccination zone II), whichever occurred last, and during which period clinical and laboratory surveillance has demonstrated no occurrence of LSD

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  44. #2720533

    26 mhí tar éis marú seamlais nó marú an cháis dheireanaigh, nó tar éis anvacsaínithedeiridh má úsáideadh vacsaíniú próifiolacsach éigeandála (i gcrios vacsaínithe II), cibé acu is déanaí a tharla, tréimhse ar lena linn nár léiríodh le faireachas cliniciúil amháin aon tarlú de LSD

    26 months after the slaughter or killing of the last case, or after the last vaccination if emergency protective vaccination has been used (in vaccination zone II), whichever occurred last, and during which period clinical surveillance alone has demonstrated no occurrence of LSD

    Commission Delegated Regulation (EU) 2023/361 of 28 November 2022 supplementing Regulation (EU) 2016/429 of the European Parliament and the Council as regards rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases (Text with EEA relevance)

  45. #2795994

    Is galar veicteoir-iompartha é galar an chraicinn chnapánaigh, arb é is cúis leis víreas ghalar an chraicinn chnapánaigh, galar a bhíonn ar bhó-ainmhithe agus is cúis le caillteanais eacnamaíocha nach beag, laghdú ar an tál bainne, cnaíteacht thromchúiseach, damáiste buan do sheithí, roinnt deacrachtaí tánaisteacha agus éineart ainsealach ar feadh míonna, agus toirmisc thrádála.

    Infection with lumpy skin disease (LSD) virus, caused by lumpy skin disease virus (LSDV), is a vector-borne disease of bovine animals that causes substantial economic losses, reduces milk yield, causes severe emaciation, permanent damage to hides, several secondary complications, months-long chronic debility, and incurs trade bans.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  46. #2796004

    Tháinig Rialachán Tarmligthe (AE) 2023/361 ón gCoimisiún i bhfeidhm an 12 Márta 2023, agus leagtar rialacha síos leis maidir le húsáid táirgí íocshláinte tréidliachta áirithe chun galair liostaithe áirithe a chosc agus a rialú, lena n-áirítear rialacha maidir le vacsaíniú in aghaidh ghalar an chraicinn chnapánaigh.

    Commission Delegated Regulation (EU) 2023/361, entered into force on 12 March 2023, and it lays down rules for the use of certain veterinary medicinal products for the purpose of prevention and control of certain listed diseases, including rules for vaccination against LSD.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  47. #2796006

    Ina theannta sin, le Rialachán Tarmligthe (AE) 2023/361 leagtar síos rialacha agus srianta i ndáil le bó-ainmhithe atá vacsaínithe in aghaidh ghalar an chraicinn chnapánaigh agus i ndáil leis na táirgí geirmeacha agus na seachtháirgí ainmhithe neamhphróiseáilte uathu, ar rialacha agus srianta iad a chomhfhreagraíonn do na rialacha agus srianta a leagtar síos i Rialachán Cur Chun Feidhme (AE) 2021/1070, seachas na rialacha agus srianta a bhaineann leis na hoibleagáidí ar oibreoirí maidir le deimhnithe sláinte ainmhithe.

    In addition, Delegated Regulation (EU) 2023/361 lays down rules and restrictions in relation to bovine animals vaccinated for LSD, their germinal products and unprocessed animal by-products thereof that correspond to the rules and restrictions laid down in Implementing Regulation (EU) 2021/1070, except for those related to the operators’ obligations with regard to animal health certificates.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  48. #2796010

    Tá a gcláir vacsaínithe in aghaidh ghalar an chraicinn chnapánaigh le haghaidh 2023 curtha faoi bhráid an Choimisiúin ag an mBulgáir agus ag an nGréig cheana féin, agus rinneadh meastóireacht ar na cláir sin agus formheasadh iad faoi chuimsiú Rialachán (AE) 2021/690 ó Pharlaimint na hEorpa agus ón gComhairle.

    Bulgaria and Greece have already submitted their 2023 LSD vaccination programmes to the Commission, and these have already been evaluated and approved, in the framework of Regulation (EU) 2021/690 of the European Parliament and of the Council.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)

  49. #2796012

    I bhfianaise Rialachán Cur Chun Feidhme (AE) 2021/1070 a bheith imithe in éag, tá sé ríthábhachtach na limistéir a shainítear mar chriosanna vacsaínithe I agus II sa Bhulgáir agus sa Ghréig i ndáil le galar an chraicinn chnapánaigh a liostú, ar criosanna vacsaínithe iad a chomhfhreagraíonn do chriosanna srianta I agus II de Rialachán Cur Chun Feidhme (AE) 2021/1070, agus tá sé ríthábhachtach freisin rialacha breise a leagan síos i ndáil leis na hoibleagáidí ar oibreoirí maidir le deimhnithe sláinte ainmhithe i dtaca le gluaiseachtaí bó-ainmhithe, agus i dtaca le gluaiseachtaí táirgí geirmeacha agus seachtháirgí ainmhithe neamhphróiseáilte uathu, ó chriosanna vacsaínithe I agus II, lasmuigh de na criosanna sin, chun a áirithiú go mbeidh faisnéis sláinte leordhóthanach chruinn le fáil sna deimhnithe sláinte ainmhithe sin agus go mbeidh siad leanúnach leis na bearta a bhí ann roimhe sin.

    In view of the expiry of Implementing Regulation (EU) 2021/1070, it is essential to list the areas defined as vaccination zones I and II in relation to LSD, in Bulgaria and Greece, that correspond to the restricted zones I and II of Implementing Regulation (EU) 2021/1070, and to lay down additional rules regarding the operators’ obligations with regard to animal health certificates for movements of bovine animals, as well as those for germinal products and unprocessed animal by-products thereof, from vaccination zones I and II, outside these zones, to ensure that these animal health certificates provide adequate and accurate health information and there is a continuity with the measures previously in place.

    Commission Implementing Decision (EU) 2023/1521 of 19 July 2023 concerning certain special disease control measures for a limited period of time relating to infection with lumpy skin disease virus in certain Member States (notified under document C(2023) 4811) (Text with EEA relevance)